A surveillance network for meningococcal disease in Europe.
about
Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding proteinReview of meningococcal group B vaccines.Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.An epidemiological review of changes in meningococcal biology during the last 100 yearsGlobal practices of meningococcal vaccine use and impact on invasive disease.Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor h binding.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.In silico studies of outer membrane of Neisseria meningitidis por a: its expression and immunogenic propertiesThe effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age.Prevalence and clinical course in invasive infections with meningococcal endotoxin variants.In-hospital management of children with bacterial meningitis in Italy.Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.A decade of invasive meningococcal disease surveillance in Poland.Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines.Meningococcal glycoconjugate vaccines.Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil.Meningococcal vaccine antigen diversity in global databases.Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisationClonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.The spectrum of acute bacterial meningitis in elderly patients.Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study.A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years.Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersOpa protein repertoires of disease-causing and carried meningococciBactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxinAntibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine.fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules.Global epidemiology of invasive meningococcal disease.Resolution of a Protracted Serogroup B Meningococcal Outbreak with Whole-Genome Sequencing Shows Interspecies Genetic TransferVaccination against meningitis B: is it worth it?Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when?The epidemiology of meningococcal disease and the impact of vaccines.
P2860
Q28554935-94B229B8-7A1E-4ED2-AB4C-5E1FF61F5C48Q30157650-E1969AC3-ABC6-4DFB-B17C-2A19B5E510C0Q33646965-526E3887-7C09-4E11-9E92-28187681FC06Q33703560-4780A2AF-0C62-4F66-AD0A-490F73CC2143Q33743483-21E06A8A-A3C0-4189-AB97-C9FF120616F5Q33850814-7EDD52C8-4A93-4A33-BBBF-9CAF6C113DB2Q33850840-EBB61F5B-37E9-4EF8-BA77-F80027B02F45Q33913048-8845600C-104E-4669-BAE3-E2A51BDCA127Q33962709-39CEF768-30B5-46FB-878E-77F43191C774Q34170021-D08E27D0-FE00-4DA1-BA53-273286F373B0Q34221093-6222F7F8-F3BA-4AC8-91C2-B4F09FACDED8Q34270429-FBA06898-D109-4F5D-9A2D-988960A2D414Q34290891-6510ABE6-A492-41A5-9722-1F1DC9E5AE42Q34499619-1DBDF83B-1274-4C5F-A202-453023A179FCQ34587235-0585FF9C-8023-4110-BCE3-BBF16DD4C970Q34618580-B2FA718F-4619-41EF-88C6-6522E8D4F81EQ34972731-1725C740-2AF4-4C77-A450-80CEA4799BEAQ35006862-5FC7ADC7-B97D-4BF8-BB92-7B4B9FCFA3CBQ35194824-36B1EAB8-1607-453A-9A57-DBFC218FF2FEQ35680467-0D0E7AD3-473F-44D6-8602-C75B551D7137Q35871107-1DB1BE01-8B3D-4874-A1BA-0CF5267D627AQ36103475-173B27EE-7120-41AF-AA1F-35C69F5C05C8Q36363154-E4A689A5-2A1B-47CC-8EA1-A80854A712A1Q36689043-E4C0D465-8B10-4E67-A9BB-7EA37B3D019DQ36710765-0935FCBA-BE8B-472E-A6CC-6C9DC7A6355DQ36781534-1635976C-C78C-4909-95B2-50C579E41E5BQ36849830-D65995BE-3C60-438B-8291-900B0A6B2B14Q36849834-D6BC1DAF-5A4D-4A05-89F8-2E758ADE3BD1Q36898329-7AD5D125-6098-4119-BBA7-08948E4968E6Q37126987-4C537987-E475-413B-B2D1-8A280853FAB0Q37130274-2647B08F-4CF0-4DD5-A7ED-376D1A67472BQ37130358-18578198-AA51-49CA-A981-4A38ED1CB95EQ37333471-10CF2D68-5EA5-40C2-A827-052ADE501335Q37359946-747A62D6-34FB-4EE5-990E-DD379286523EQ37434278-16406785-052A-41E9-9833-97D4AFC13FE9Q37449169-939B277D-4E61-4968-8D36-1F9538D654E3Q37461347-5C86FA98-6DB6-4CEF-9FB4-6EAEDAFF4741Q37524027-C33B1EB7-62C6-49FB-8DDC-7DD8C43CE2A9Q37626017-C943606D-E5B6-4FA2-A875-A084FF0FF68AQ37706585-7DE91E1F-DA92-4151-8F6D-D1B674A73DED
P2860
A surveillance network for meningococcal disease in Europe.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A surveillance network for meningococcal disease in Europe.
@ast
A surveillance network for meningococcal disease in Europe.
@en
type
label
A surveillance network for meningococcal disease in Europe.
@ast
A surveillance network for meningococcal disease in Europe.
@en
prefLabel
A surveillance network for meningococcal disease in Europe.
@ast
A surveillance network for meningococcal disease in Europe.
@en
P2093
P2860
P50
P1476
A surveillance network for meningococcal disease in Europe
@en
P2093
Carina Brehony
Manosree Chandra
Sigrid Heuberger
P2860
P356
10.1111/J.1574-6976.2006.00060.X
P577
2006-12-01T00:00:00Z